UPDATE: JPMorgan Starts Vir Biotechnology (VIR) at Overweight

November 5, 2019 4:13 AM EST Send to a Friend
(Updated - November 5, 2019 4:58 AM EST)

(updated comment)JPMorgan analyst Anupam Rama initiates coverage on Vir Biotechnology (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login